ADHEREX TECHNOLOGIES INC. (USA) |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05-15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
| 05-14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
Chart calendar Adherex Technologies Inc. (USA)
89b.Ig3dqVe9qU8fTOsABGisQX-TPONtjd_wGJBVirHyvvw.cVuV6hXpwDhzJIVoMQ_6eAbSXbY_67GKdKc_s-Kk2LBPb6uZPsrBAykDqg~c809c01fa87761c628d89786f5cc86a8
Upcoming events on Adherex Technologies Inc. (USA)
Past events on Adherex Technologies Inc. (USA)
| 2024-05-14 08:30 | Q1 2024 Earnings Call |
| 2024-05-14 06:03 | Q1 2024 Earnings Release |
| 2024-03-21 08:30 | Q4 2023 Earnings Call |
| 2024-03-21 06:00 | Q4 2023 Earnings Release |
| 2023-11-16 05:00 | Jefferies London Healthcare Conference |
| 2023-11-15 | Craig-Hallum Alpha Select Conference |
| 2023-11-06 08:30 | Q3 2023 Earnings Call |
| 2023-11-06 05:59 | Q3 2023 Earnings Release |
| 2023-09-27 15:00 | Cantor Global Healthcare Conference |
| 2023-09-12 13:30 | H.C. Wainwright Global Investment Conference |
| 2023-08-07 | Wedbush PacGrow Healthcare Conference |
| 2023-08-03 08:30 | Q2 2023 Earnings Call |
| 2023-08-03 05:59 | Q2 2023 Earnings Release |
| 2023-06-12 10:00 | Annual General Meeting |
| 2023-05-11 08:30 | Q1 2023 Earnings Call |
| 2023-05-11 06:01 | Q1 2023 Earnings Release |
| 2023-03-30 05:55 | Q4 2022 Earnings Release |
| 2022-11-11 07:10 | Q3 2022 Earnings Release |
| 2022-08-12 06:59 | Interim 2022 Earnings Release |
| 2022-06-15 14:30 | JMP Securities Life Sciences Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,17 0,00 - | 0,00 0,00 - | 1,54 0,74 106.09% | 21,3 20,5 3.76% | 63,1 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 -6,00 - | 24,3 |
|
EBIT Million USD | Released Forecast Spread | -13,0 -11,7 -11.27% | -17,9 -20,1 11.12% | -17,2 -17,6 2.15% | -22,6 -23,7 4.68% | -12,8 -11,0 -16.58% | 14,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,8 -11,5 -11.55% | -18,1 -20,4 11.25% | -17,3 -17,5 0.99% | -23,7 -24,3 2.4% | -12,8 -8,58 -48.81% | 10,4 |
|
Net income Million USD | Released Forecast Spread | -12,8 -11,5 -11.55% | -18,1 -20,4 11.25% | -17,3 -17,5 0.99% | -23,7 -24,3 2.4% | -16,0 -8,59 -86.8% | 11,9 |
|
EPS USD | Released Forecast Spread | -0,64 -0,55 -16.36% | -0,76 -0,86 11.63% | -0,67 -0,67 0% | -0,90 -0,92 1.82% | -0,60 -0,53 -14.07% | 0,41 |
| Announcement Date | 14/02/20 | 30/03/21 | 28/02/22 | 29/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1,54 0,74 106.09% | 1,68 1,85 -9.18% | 3,33 3,73 -10.82% | 6,52 5,34 22.08% | 9,74 8,97 8.54% | 25,4 18,9 34.4% | 11,5 | 12,5 | 13,0 | 16,5 | 16,1 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,40 | 3,00 | 5,50 | 15,0 | 7,30 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -3,55 -3,66 3.13% | -5,01 -3,56 -40.64% | -7,90 -4,81 -64.11% | -6,14 -7,24 15.31% | -5,27 -5,03 -4.72% | -4,67 -3,90 -19.51% | -1,02 -2,84 64.2% | -1,82 -0,36 -401.17% | 13,7 6,29 118.47% | 0,32 | 1,39 | 1,28 | 4,96 | 1,82 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,70 -3,65 -1.26% | -5,07 -3,58 -41.87% | -8,09 -4,85 -66.66% | -6,86 -7,37 6.91% | -6,05 -5,76 -5.14% | -5,44 -4,28 -27.12% | -1,87 -3,27 42.82% | -1,82 -0,47 -283.06% | 12,8 6,97 84.1% | -0,06 | 0,46 | 0,06 | 4,10 | 1,01 |
|
Net income Million USD | Released Forecast Spread | -3,70 -3,65 -1.26% | -5,07 -3,58 -41.87% | -8,09 -4,85 -66.66% | -6,86 -7,37 6.91% | -6,05 -5,76 -5.14% | -5,44 -4,28 -27.12% | -1,87 -3,27 42.82% | -2,68 -0,48 -456.43% | 12,8 5,71 124.63% | -0,25 | 0,85 | 0,87 | 3,70 | 0,81 |
|
EPS USD | Released Forecast Spread | -0,14 -0,14 0% | -0,19 -0,14 -39.02% | -0,31 -0,18 -70.64% | -0,26 -0,27 1.89% | -0,23 -0,21 -9.52% | -0,21 -0,16 -34.04% | -0,07 -0,12 41.67% | -0,10 -0,02 -400% | 0,41 0,21 92.19% | -0,01 | 0,03 | 0,03 | 0,13 | 0,10 |
| Announcement Date | 12/05/22 | 12/08/22 | 11/11/22 | 29/03/23 | 11/05/23 | 03/08/23 | 06/11/23 | 21/03/24 | 14/05/24 | - | - | - | - | - |
More events
Past sector events for Adherex Technologies Inc. (USA)
| 2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-15 16:01 | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- FENC Stock
- Stock
- Calendar Adherex Technologies Inc. (USA)